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Abstract
Background: Post-term pregnancy, a pregnancy exceeding 294 days or 42 completed weeks, is associated with
increased perinatal morbidity and mortality and is considered a high-risk condition which requires specialist surveillance
and induction of labour. However, there is uncertainty on the policy concerning the timing of induction for post-term
pregnancy or impending post-term pregnancy, leading to practice variation between caregivers. Previous studies on
induction at or beyond 41 weeks versus expectant management showed different results on perinatal outcome though
conclusions in meta-analyses show a preference for induction at 41 weeks. However, interpretation of the results is
hampered by the limited sample size of most trials and the heterogeneity in design. Most control groups had a policy
of awaiting spontaneous onset of labour that went far beyond 42 weeks, which does not reflect usual care in The
Netherlands where induction of labour at 42 weeks is the regular policy. Thus leaving the question unanswered if
induction at 41 weeks results in better perinatal outcomes than expectant management until 42 weeks.
Methods/design: In this study we compare a policy of labour induction at 41 + 0/+1 weeks with a policy of expectant
management until 42 weeks in obstetrical low risk women without contra-indications for expectant management until
42 weeks and a singleton pregnancy in cephalic position. We will perform a multicenter randomised controlled clinical
trial. Our primary outcome will be a composite outcome of perinatal mortality and neonatal morbidity. Secondary
outcomes will be maternal outcomes as mode of delivery (operative vaginal delivery and Caesarean section), need for
analgesia and postpartum haemorrhage (≥1000 ml). Maternal preferences, satisfaction, wellbeing, pain and anxiety will
be assessed alongside the trial.
Discussion: This study will provide evidence for the management of pregnant women reaching a gestational age of
41 weeks.
Trial registration: Dutch Trial Register (Nederlands Trial Register): NTR3431. Registered: 14 May 2012.
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Background
Post-term or prolonged pregnancy, defined as a pregnancy
extended to or beyond 42 + 0 weeks or ≥ 294 days after
the first day of last menstrual period, is associated with in-
creased perinatal morbidity and mortality [1-10]. There-
fore post-term pregnancy is considered as a high-risk
condition which requires specialist surveillance and induc-
tion of labour at some stage, mainly because of a relative
small group of undetected growth-restricted foetuses that
is at risk for adverse perinatal outcome [11,12].
In this era, with gestational age based on first trimester
ultrasound, the incidence of post-term pregnancy is re-
duced to 3-5% or even less [13-15]. The risk on adverse
perinatal outcome is considered to increase gradually ra-
ther than a steep increase from 42 weeks onwards, though
the literature on this subject is ambiguous [16-18]. The
Cochrane review on induction of labour for improving
birth outcomes showed that a policy of labour induction
at or beyond 41 completed weeks is associated with sig-
nificant fewer perinatal deaths (22 trials, 9383 participants,
RR 0.31 [95% CI 0.12-0.88]) although the absolute risk of
perinatal death is small [18]. According to this review,
labour induction doesn’t increase the risk of Caesarean
section in women with a gestational age of 41 or 42 com-
pleted weeks [18]. However, only a few of the included
studies had a policy of labour induction at 41 weeks in the
intervention group. In other studies it is unclear whether
labour was always induced at 41 weeks. Furthermore in
most trials expectant management in the control groups
continued far beyond 42 weeks [17-20]. In addition, recent
observational studies showed that elective induction leads
to similar increased maternal and foetal risks as induction
on medical indication, in comparison to spontaneous on-
set of labour [21]. Recent meta-analysis showed that in-
duction of labour on maternal or foetal indication in
women with intact membranes reduces the risk of Caesar-
ean section, thus leaving the question unanswered if in-
duction at 41 weeks in obstetrical low risk women gives
better perinatal outcomes and maternal outcomes than
expectant management until 42 weeks [19,22].
Because of the uncertainty regarding the management of
(impending) post-term pregnancy, there is no consensus on
the optimal timing of induction, leading to practice vari-
ation. Policy concerning low risk pregnancies at or beyond
41 weeks in the Netherlands varies from expectant manage-
ment until 42 weeks, without extra surveillance, to once or
twice a week cardiotocography (CTG) and ultrasound sur-
veillance in secondary care from 41 weeks onwards and
labour induction at 42 weeks, or labour induction starting
at 41 weeks [23]. Until now, the interdisciplinary
agreement between the Royal Dutch Organisation of
Midwives (KNOV) and the Dutch Society for Obstet-
rics and Gynaecology (NVOG) concerning post-term
pregnancy in the Netherlands, indicates secondary care
and labour induction from 42 weeks onwards [8,24].
However, more and more hospitals are converting their
policy to induction of labour at 41 weeks, though there
is no consensus concerning this change of policy. Op-
ponents argue that hospitalised labour will diminish
physiological birth, with increased rates of pain treatment,
and operative delivery (vacuum/forceps c.q. Caesarean
section) resulting in more negative birth experiences and
an increase in costs with doubtful perinatal benefits
[20,25-28]. Unfortunately, data reflecting the Dutch situ-
ation, comparing induction of labour at 41 weeks with ex-
pectant management until 42 weeks, are lacking.
Observational data of the Dutch Perinatal Registry
(PRN 2000 - 2006) show very small, but increasing rates
of adverse perinatal outcomes such as Apgar score <7
(40 + 0-40 + 6 weeks 0.9%, 41 + 0-41 + 6 weeks 1.1%
and ≥ 42 weeks 1.4%), meconium aspiration syndrome
(40 + 0-40 + 6 weeks 0.12%, 41 + 0-41 + 6 weeks 0.21%
and ≥ 42 weeks 0.25%) and NICU admission (40 + 0-40 +
6 weeks 0.49%, 41 + 0-41 + 6 weeks 0.62% and ≥ 42 weeks
0.91%), among births from singleton pregnancies [29].
However, perinatal mortality (up to 28 days) of single-
tons born between 41 + 0 – 41 + 6 weeks (0.16%) was
comparable to perinatal mortality between 40 + 0 – 40 +
6 weeks (0.13%) and between 39 + 0 – 39 + 6 weeks
(0.16%) [30]. PRN data also showed an increase in op-
erative vaginal delivery when labour is induced beyond
41 weeks compared to induction at term (37 + 0-39 + 6
9.8%, 40 + 0-40 + 6 weeks 12.4%, 41 + 0-41 + 6 weeks
14.6% and ≥ 42 weeks 17.1%) [31].
Previous studies comparing expectant management
and induction of labour in high risk pregnancies showed
a discrepancy between observational PRN data and data
from randomised trials (Digitat trial (growth retardation)
and Hypitat trial (hypertension at term)) [32,33]. The
PRN database indicated an increased risk of operative
vaginal delivery after induction of labour, whereas the
subsequent randomised clinical trials showed that such
an effect was absent [32-34]. Also PRN data showed a
significant increase in Caesarean section after labour in-
duction at or beyond 41 completed weeks compared to
spontaneous onset of labour. However, Caesarean sec-
tion rates in the Netherlands between 2000-2006 are
much lower than in many other western countries (for
singletons overall 9.4% between 41 + 0-41 + 6 weeks and
16.6% beyond 42 weeks) thus hampering the extrapola-
tion of results from international studies, and emphasis-
ing the importance of this trial [29,30].
Ethnic differences are likely to play an important role in
post-term pregnancy. The mean duration of pregnancy is
shorter in women from African origin and Indian origin
as compared to Caucasian women [35]. Indeed, the inci-
dence of stillbirth is higher from 41 weeks onwards among
women from African and Surinam-Hindustan (Indian)
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origin as compared to Caucasian women [35,36]. Though
guidelines are not adjusted yet to ethnic origin, we will
register ethnicity in our study.
We are not aware of other ongoing studies that are simi-
lar to the present study proposal or related to the problem
discussed here (national or international). The issue of the
timing of induction of labour in post-term pregnancy has
been addressed in many studies showing that labour in-
duction should be offered in case of post-term pregnancy
because of the increased risk of perinatal mortality and
morbidity [8,19].
The 41-42 weeks dilemma considers a large proportion
of pregnant women, as with a policy of labour induction
at 41 weeks 18% (31,166/173,099) of all pregnant women
in The Netherlands would be induced, compared to 1.5%
(2,525/173,099) at 42 weeks [37]. With a policy of expect-
ant management 68.7% will have spontaneous onset of
labour between 41 + 0 – 41 + 6 weeks [37]. Before the
introduction of the most recent guideline on management
of post-term pregnancy in 2007 [38], there were less in-
ductions of labour between 41 + 0 and 41 + 6 weeks (2006
18,2% (30,903), 2007 18,0% (30,151) and more deliveries
after 42 weeks (2006 4,9% (8,312), 2007 4,5% (7,550)) [39].
Because of the controversy on this issue between care-
givers, and the fact that the policy in surrounding coun-
tries is different, we feel that a nationwide randomised
clinical trial is the obvious and necessary step to come to a
multidisciplinary guideline regarding (impending) post-
term pregnancy. We will conduct a randomised controlled
trial to evaluate the effectiveness of a policy of labour in-
duction at 41 weeks compared to expectant management
until 42 weeks in women without contra-indications for
expectant management.
Methods/design
The study is set in the Dutch Obstetric Consortium: a col-
laboration of obstetric centers in the Netherlands in co-
operation with the Midwifery Research Network of the
Netherlands (MRNN) [40]. Approximately 200 centers, in-
cluding university hospitals, teaching hospitals, non-
teaching hospitals and midwifery practices will participate
in this trial [24].
We will ask obstetrical low risk women ≥ 18 years with a
singleton pregnancy in stable cephalic position and a cer-
tain gestational age of 40 + 5 - 41 + 0, based on first trimes-
ter ultrasound and without contra-indications for
expectant management until 42 weeks for consent to par-
ticipate in our study and to be allocated to induction of
labour at 41 + 0/+1 weeks or at 42 + 0 weeks. Exclusion
criteria are age <18 years, uncertain gestational age, ob-
stetrical indications for secondary care (e.g. hypertension
(systolic 140 mmHg and/or diastolic 90 mmHg or more),
proteinuria (≥3 g/L), pre-existent maternal heart or kidney
diseases, gestational diabetes, previous Caesarean section,
multiple pregnancy, intra-uterine growth retardation)
and non-reassuring fetal status (no fetal movements,
abnormal fetal heart rate, known fetal abnormalities
which could influence perinatal outcome, including ab-
normal karyotype, ruptured membranes at time of ran-
domisation and a non-reassuring fetal status at time of
randomisation). The results of the randomised clinical
trial will be analysed according to the intention to treat
principle.
Intervention group: induction of labour at 41 + 0 or 41 +
1 weeks
Women randomised to induction of labour will be re-
ferred to the cooperating hospital for induction of labour
according to local protocol. Induction of labour will be
started at 41 + 0 to 41 + 1 weeks. Women with a cervix
that is judged to be ‘ripe’ at vaginal examination (Bishop
Score of 6 or more), will have labour induced with
amniotomy followed by intravenous oxytocin according
to local protocol. In case rupturing of membranes is not
possible, cervical ripening will be accomplished in ac-
cordance with our national guidelines. In case the cervix
is judged to be still unripe the day after priming, cervical
ripening will be repeated. All patients in the intervention
group will be monitored until after delivery.
Control group: expectant management until 42 weeks
Women allocated to expectant management await
spontaneous onset of labour until 42 weeks. If labour
has not started, monitoring is according to local proto-
col. This reflects current care in The Netherlands. Mon-
itoring can consist of consultations, electronic fetal
heart rate monitoring and ultrasound assessment of am-
niotic fluid. An increase of the frequency of these
checks as well as admission to the hospital is based on
the judgment of the midwife or clinician in charge as
usual. In the expectant management group, intervention
will occur in case the fetal condition does not justify ex-
pectant management, such as reduced fetal movements
reported by the mother, non-optimal fetal heart rate on
CTG or oligohydramnios [12]. If an indication for in-
duction of labour occurs, such as prelabour rupture of
membranes for >24 hours or meconium stained amni-
otic fluid, referral to secondary care for labour induc-
tion is indicated according to the management
strategies which are recorded in the national Obstetrical
Indication List [41]. All diagnostic tests and interven-
tions between randomisation and birth are registered in
the case report form. Protocol violation is noted in the
case report form with the reason of switch of policy to
induction of labour. Women with uncomplicated preg-
nancies who are still in primary care will be referred to
secondary care at 42 + 0 weeks for induction of labour
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following the procedure as stated for the intervention
group.
Outcome measures
Primary
Primary outcome will be a composite of perinatal mortal-
ity and neonatal morbidity. Adverse perinatal outcome is
defined as a composite of perinatal mortality, a 5-minute
Apgar-score below 7 and/or an arterial pH below 7.05 (as
in other Consortium studies [32,33]), meconium aspir-
ation syndrome, plexus brachialis injury (with and without
association with shoulder dystocia (additional manoeuvres
to deliver shoulders)) and/or NICU admission (level of
care and duration). Meconium aspiration syndrome is de-
fined as respiratory distress in the first four hours after
birth in presence of meconium stained amniotic fluid and
categorised as severe (requiring assisted mechanical venti-
lation) or moderate (requiring oxygen for at least 48 hours
or at a concentration of 40 percent or greater but without
mechanical ventilation).
Secondary
Secondary outcomes will be maternal outcomes such as
operative delivery (operative vaginal delivery, Caesarean
section), need for analgesia (epidural, remifentanil, pethi-
din), post-partum haemorrhage ≥ 1000 ml and severe
perineal injury (third- or fourth-degree perineal tear).
Maternal preferences, satisfaction, wellbeing and anx-
iety will be assessed alongside the trial [42,43].
Measurements
When a patient fulfils the study criteria and written in-
formed consent is obtained, clinical data such as age,
height, weight before pregnancy, ethnicity, highest fin-
ished education and social economic status based on
postal code are collected at study-entry [44]. Obstetric
history and level of care in current pregnancy are regis-
tered. Cervical ripeness will be assessed by digital exam-
ination of the cervix. The acquired Bishop score (based
on dilatation, effacement, consistency, position and en-
gagement) will be noted and fetal condition will be
checked according to local protocol. Eligible women will
be randomised subsequently.
After randomisation, number and lengths of admissions
is noted. In the expectant management group, level of care
and number of (outpatient clinic) visits is reported. At
each visit, maternal and fetal assessments are recorded.
At the onset of labour all relevant data will be col-
lected including start of labour. Data on first, second
and third stage of labour are collected, including treat-
ment for pain relief, mode of delivery and adverse peri-
natal and maternal outcomes.
Perinatal and maternal mortality and morbidity will be
specified.
Data will be collected until women and child are dis-
charged home for the first time or when deceased. If a
participant withdraws from the study, the reason (lost to
follow up, withdrawal of consent, prematurely stop of
study) will be registered.
We will use standardised case report forms that have
been established in previous studies.
Apart from the collection of clinical data, a sub-cohort
of women will complete questionnaires addressing health
related quality of life and wellbeing (EQ 6D [45], state anx-
iety (STAI [46]), preferences and satisfaction (SSQ [47,48],
LADY-X [49]), as well as questionnaires containing infor-
mation on pain (PCS [50], NPRS/VAS) [51,52]. Question-
naires will be completed at baseline after randomisation,
and 6 weeks after delivery. Women can fill out the ques-
tionnaires online or on paper.
Women who do not give consent for randomisation
will be treated according to the local protocol and they
will be followed in a prospective cohort study.
Follow up of women and infants
The last questionnaires will be filled out at 6 weeks
post-partum. Informed consent will be asked for future
follow up studies.
Procedures, recruitment, randomisation and collection of
baseline data
Randomisation will be performed through ALEA, a web-
based software program for randomisation in clinical tri-
als. The database is located in the central data collection
unit in the Academic Medical Center in Amsterdam.
Randomisation procedure is by individual randomisa-
tion. Women will be randomly allocated to either induc-
tion of labour or expectant management. We will collect
data from women who refuse randomisation due to a
strong preference for one of the treatment options or
because they want to follow local policy. The study will
be an open label study, as it is impossible to blind the
health care workers and patients for the strategy to
which the woman is allocated.
Data safety
This nationwide trial will be carried out by midwives (pri-
mary care) and gynaecologists (secondary care). To ensure
the quality of this study and to minimize the protocol vio-
lations, a website is launched with all study information.
All sites will be informed by the researchers on the proce-
dures. All sites have the possibility to consult (in person or
by phone) the researchers of the study group and an email
address is available for non urgent questions. All data are
entered by research midwives or research nurses or
trained medical students. After 900 inclusions, an interim
analysis will be performed on safety. The operating proce-
dures of the study are discussed with a data safety
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monitoring board, an independent group of experts who
gave their approval to the design of the study safety.
Serious adverse events
The following serious adverse events (SAE) will be iden-
tified: Perinatal death, maternal death, severe neonatal
morbidity (NICU admission), severe maternal morbidity
(IC/CCU admission), event related to induction of labour
and uterine rupture, asphyxia and meconium aspiration
with admission of the neonate on the NICU/High Care
department. The Data Safety Monitoring Board will be in-
formed if three SAE of the neonate will occur or one ma-
ternal SAE. All SAE are reported to the main investigators
within 24 hours. They will report to the data safety moni-
toring board.
Ethical consideration and trial registration
This study has been approved by the national central com-
mittee on research involving Human Subjects (CCMO- NL
38455.018.11), by the Medical Ethical Committee, Academic
Medical Center, Amsterdam the Netherlands (METC: 2011/
361). The study will be a multicenter randomised controlled
trial. The participating hospitals got approval of their local
boards. The trial was registered at the Dutch Trial Register
(Nederlands Trial Register): NTR3431.
Statistical issues
Sample size calculation
Sample size was calculated for non-inferiority testing
using software Queary Advisor 7.0. Based on the inci-
dence of the composite adverse perinatal outcome, the
sample size is calculated at 900 women per group (1800
women in total) [53]. With this sample size, a two-group
large-sample normal approximation test of proportions
with a one-sided 0.050 significance level will have 80%
power to reject the null hypothesis that labour induction
and expectant monitoring are not equivalent (the differ-
ence in proportions, is 0.020 or further from zero in the
same direction) in favour of the alternative hypothesis
that the proportions in the two groups are equivalent,
assuming that the expected difference in proportions on
composite adverse perinatal outcome is 0.000 and the
proportion in the standard group is 0.030.
When there is no equivalence this sample size (900 pa-
tients per group) will allow us to have 85% statistical
power to detect 2% reduction in the risk of composite
perinatal mortality and neonatal morbidity from 3% to 1%.
Data analysis
The results of the randomised clinical trial will be ana-
lysed according to the intention to treat principle. The
effectiveness of labour induction at 41 weeks versus ex-
pectant management until 42 weeks will be assessed by
calculating relative risks and 95% confidence intervals.
Time to delivery will be compared using Kaplan-Meier
curves and log-rank tests.
Discussion
The policy regarding the timing of labour induction for
(impending) post-term pregnancy is still under debate be-
cause of the inconclusiveness of the literature whether or
not labour should be induced at 41 weeks or at 42 weeks
for the prevention of adverse perinatal outcome. Most
studies on labour induction or expectant management for
(impending) post-term pregnancy started intervention be-
yond 41 weeks and continued expectant management far
beyond 42 weeks. Until now, the Dutch guideline on post-
term pregnancy indicates labour induction at 42 weeks.
However, policy is moving towards labour induction at
41 weeks, though there is no consensus on this policy.
This study will provide sufficiently precise and unbiased
evidence on the difference between both strategies in peri-
natal and maternal outcome and patient preferences.
When our study shows that the incidence of poor neo-
natal and maternal outcome is very low and comparable
with both strategies, this will in itself be an argument
against intervention. Maternal preferences will then be
leading in the choice between induction or expectant
management. This study will help to achieve an evidence-
based management strategy concerning impending post-
term pregnancy.
We will adhere to the CONSORT guidelines for
reporting the trial.
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